Forchheim, Germany Clinical Trials

A listing of Forchheim, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study

RDN-CKD Study is a prospective, randomized (1:1, central randomization), double-blind (unblinded interventionalist and blinded study team at each center), sham controlled, multicenter feasibility study. The purpose of the RDN-CKD Study is to demonstrate that renal denervation (RDN) effectively reduces 24-h ambulatory BP in 80 patients with chronic kidney disease (CKD) …

Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg
 (8.7 away) Contact site
  • 0 views
  • 23 Jan, 2021
  • +5 other locations
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)

The aim of this study is to assess the therapeutic efficacy of secukinumab on the psoriatic skin and to explore the anti-inflammatory (reduction of hepatic inflammation and cell damage), anti-steatotic (reduction of hepatic triglyceride content) and anti-fibrotic (reduction of hepatic fibrosis) effects of secukinumab in patients with psoriasis and coexisting …

hepatic fibrosis
systemic therapy
secukinumab
fibrosis
liver disease
Novartis Investigative Site
 (8.7 away) Contact site
  • 5 views
  • 11 May, 2021
  • +19 other locations
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

cholangitis
cirrhosis
Universitatsklinikum Erlangen
 (8.7 away) Contact site
  • 80 views
  • 16 Jun, 2021
  • +41 other locations
Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML

This trial compares outcome of two treatment strategies for patients with high-risk AML who failed to achieve or maintain a complete remission with standard therapy. Patients will be randomized between two strategies. The standard strategy is aimed at achieving a complete remission by aggressive salvage chemotherapy using high dose cytarabine …

induction chemotherapy
carbon monoxide
blast cells
cytarabine
neoadjuvant therapy
Universit tsklinikum Erlangen
 (8.7 away) Contact site
  • 45 views
  • 24 Jan, 2021
  • +17 other locations
Short-course Radiotherapy Versus Chemoradiotherapy Followed by Consolidation Chemotherapy and Selective Organ Preservation for MRI-defined Intermediate and High-risk Rectal Cancer Patients

The hereby proposed ACO/ARO/AIO-18.1 randomized trial aims to directly compare the newly established TNT concepts applying either short-course RT according to RAPIDO, or CRT according to CAO/ARO/AIO-04/-12, both followed by consolidation chemotherapy, and surgery or a watch&wait (W&W) approach for patients with clinical complete response (cCR). The ACO/ARO/AIO-18.1 study incorporates …

University Clinic Erlangen
 (8.7 away) Contact site
  • 0 views
  • 12 Jun, 2021
  • +43 other locations
Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNF -Inhibitor Treatment

The purpose of this study is to compare the safety and efficacy of secukinumab and ustekinumab in patients with active psoriatic arthritis who showed failure to previous TNF-inhibitor treatment

ustekinumab
psoriasis
secukinumab
anti-rheumatic drugs
psoriatic plaque
Novartis Investigative Site
 (8.7 away) Contact site
  • 0 views
  • 04 Jun, 2021
  • +24 other locations